Actinium Pharmaceuticals, Inc. Expands R&D Capabilities with New Research Facility to Enhance Development of Next Generation Antibody Radiation Conjugates Leveraging Its Proprietary AWE Platform PR Newswire NEW YORK, Oct. 14, 2020 NEW YORK, Oct. 14, 2020 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced the launch of its new research and development lab facility in New York City. This new research facility expands Actinium's internal R&D capabilities and will be focused on developing novel Antibody Radiation Conjugate (ARC) candidates, ARC therapeutic combination strategies, and supporting AWE platform research collaborations. Actinium's R&D efforts will employ a multidisciplinary approach leveraging its team's expertise and experience in cancer cell biology, radiochemistry, radiation sciences, immunology and oncology drug development. The proprietary AWE technology platform, protected by over one hundred and twenty-five patents, is the foundation for Actinium's R&D and exploits multiple different radioisotope payloads including the potent alpha-emitter, Actinium-225. (PRNewsfoto/Actinium Pharmaceuticals, Inc.) This new research facility will function under the guidance of Dr. Dale Ludwig, Ph.D. the Company's Chief Scientific & Technology Officer, who has over twenty-five years of oncology discovery research and development experience, including supporting the development and launch of Erbitux®, Cyramza^TM, Portrazza®, and Lartruvo^TM as well as the clinical advancement of at least 10 additional therapeutic antibodies and Antibody Drug Conjugates while at Eli Lilly and, previously, ImClone Systems Inc. The research facility will be managed and staffed by Ph.D. level scientists who will contribute their respective expertise in areas of drug discovery, radiation chemistry, and translational research to advance novel ARC programs and investigations into combination therapeutic strategies. "Our new research facility will allow us to significantly accelerate our preclinical and clinical development of novel ARC programs and investigate mechanistic ARC therapeutic combinations, which utilize our expertise in radioimmunobiology, our AWE Technology Platform capabilities,
Portland, OR, Oct. 13, 2020 (GLOBE NEWSWIRE) — As per the report published by Allied Market Research, the global automotive panoramic sunroof market was pegged at $1.31 billion in 2018 and is anticipated to hit $4.26 billion by 2026, registering a CAGR of 15.7% from 2019 to 2026.
Innovation in glass technology and surge in demand for safety, comfort, and convenience drive the growth of the global automotive panoramic sunroof market. However, high integration and maintenance cost and low penetration of power sunroof in low segment vehicles hinder the market growth. On the other hand, surge in penetration of solar sunroof in electric vehicles across the globe and increase in the sale of automotive vehicles would open new opportunities for the market players in the coming years.
Download Report Sample at https://www.alliedmarketresearch.com/request-sample/6281
Covid-19 impact: The ongoing pandemic has negatively impacted the global automotive panoramic sunroof industry.
- Paused production, slumped sale, and fallout in business performance has decreased the demand for the automotive panoramic sunroof.
- Manufacturers are reviewing their R&D budgets, long-term investments, and diverting funds to potentially future-proof technologies, which may halt the manufacturing of automotive panoramic sunroofs.
Get Detailed COVID-19 Impact Analysis on the Automotive Panoramic Sunroof Market Request Here!
The global automotive panoramic sunroof market is segmented on the basis of material type, vehicle type, and geography. Based on material type, the fiber segment is anticipated the highest CAGR of 21.3% during the forecast period. However, the glass segment held the largest share in 2018, accounting for more than 90% of the market.
On the basis of vehicle type, the hatchback segment is expected to manifest the fastest CAGR of 19.6% during the forecast period. However, the sedan segment dominated the market in 2018, contributing to more than half of the market.
Interested to Procure
PORTLAND, Ore., Oct. 12, 2020 /PRNewswire/ — Allied Market Research published a report, titled, “Car Finance Market by Distribution Channel (Banks, OEMs, Credit Unions, and Others), Vehicle Age (New Vehicles and Used Vehicles), Application (Personal and Commercial), and Purpose (Loans and Lease): Global Opportunity Analysis and Industry Forecast, 2020–2027.” According to the report, the global car finances industry was pegged at $1.29 billion in 2019, and is expected to hit $2.33 billion by 2027, registering a CAGR of 14.3% from 2020 to 2027.
Drivers, restraints, and opportunities-
Rise in global average price of automobiles and increase in demand for vehicles fuel the growth of the global car finance market. On the other hand, emergence of rideshare services and surge in debts from various borrowers curtail down the growth to some extent. However, enactment of technologies in existing product lines and untapped potential of emerging economies are expected to create multiple opportunities for the key players in the industry.
Get Your Free Sample Report – Download Now: https://www.alliedmarketresearch.com/request-sample/4336
- The outbreak of the pandemic has resulted in sharp decline in consumer trends and preferences toward purchasing cars. Accordingly, the global car finance market has been considerably affected. However, the overall situation is gradually being ameliorated across the world and the market is expected to get back to its position soon.
- At the same time, it’s worth mentioning that people across the world have started preferring private way of transportation over selecting public transport which, in turn, has provided the market with a mixed effect.
The banks segment to lead the trail by 2027-
Based on distribution channel, the banks segment accounted for nearly two-fifths of the global car finance market share in 2019 and is anticipated to maintain the lion’s share throughout the study period. The OEMs segment,